Multidimensional Treatment of Cancer Pain

Overview

Journal Curr Oncol Rep

Publisher Current Science

Specialty Oncology

Date 2017 Feb 22

PMID 28220448

Citations 18

Authors

Weiyang Christopher Liu

Zhong Xi Zheng

Kian Hian Tan

Gregory J Meredith

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Though numerous treatment options are available to address cancer pain, inadequate management continues to be an ongoing problem worldwide.

Recent Findings: A systematic review of the recent scientific literature was conducted with attention to new therapies along with reports of general consensus that were analyzed. Pain research continues to be difficult and though numerous guidelines have been developed, adequate powered studies are not common. Good practice would suggest a comprehensive approach to cancer pain management taking into account the many options available and treating each patient with a personalized therapeutic program. Though there is a very low number of randomized control trials, this probably reflects the difficulty in conducting these studies in heterogeneous cancer pain patient populations in sufficient numbers to yield credible study power.

Citing Articles

Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology.

Antonuzzo A, Gonella S, Blasi L, Carnio S, Franzese C, Marano L Healthcare (Basel). 2025; 13(3).

PMID: 39942401 PMC: 11816693. DOI: 10.3390/healthcare13030212.

Consensus statement on chronic pain treatment in cancer survivors.

Mamiya K, Iida H, Iseki M, Yamaguch S, Yonekura H, Ueno H J Anesth. 2024; .

PMID: 39627504 DOI: 10.1007/s00540-024-03427-0.

Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy.

Moramarco S, De Angelis L, Bernardini L, Marconi L, Piunno G, Siciliano S Cancers (Basel). 2024; 16(17).

PMID: 39272938 PMC: 11393921. DOI: 10.3390/cancers16173080.

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment.

Dorr A, Vogel I, Wittenbecher F, Westermann J, Thuss-Patience P, Ahn J Palliat Care Soc Pract. 2024; 18:26323524241260424.

PMID: 39045295 PMC: 11265252. DOI: 10.1177/26323524241260424.

Moxibustion for the Treatment of Cancer and its Complications: Efficacies and Mechanisms.

Lu S, Wang B, Wang J, Guo Y, Li S, Zhao S Integr Cancer Ther. 2023; 22:15347354231198089.

PMID: 37746720 PMC: 10521285. DOI: 10.1177/15347354231198089.

References

van den Beuken-van Everdingen M, de Rijke J, Kessels A, Schouten H, van Kleef M, Patijn J . Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; 18(9):1437-49. DOI: 10.1093/annonc/mdm056. View

Leppert W, Kowalski G . Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain. Onco Targets Ther. 2015; 8:3621-7. PMC: 4675634. DOI: 10.2147/OTT.S91347. View

Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann K, Grond S . Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001; 93(3):247-257. DOI: 10.1016/S0304-3959(01)00324-4. View

Pasutharnchat K, Tan K, Hadi M, Ho K . Intrathecal analgesia in patients with cancer pain--an audit in a tertiary institution. Ann Acad Med Singap. 2009; 38(11):943-6. View

Kress H, Aldington D, Alon E, Coaccioli S, Collett B, Coluzzi F . A holistic approach to chronic pain management that involves all stakeholders: change is needed. Curr Med Res Opin. 2015; 31(9):1743-54. DOI: 10.1185/03007995.2015.1072088. View

Schmidt-Hansen M, Bennett M, Hilgart J . Oxycodone for Cancer Pain in Adult Patients. JAMA. 2015; 314(12):1282-3. DOI: 10.1001/jama.2015.8556. View

Daeninck P, Gagnon B, Gallagher R, Henderson J, Shir Y, Zimmermann C . Canadian recommendations for the management of breakthrough cancer pain. Curr Oncol. 2016; 23(2):96-108. PMC: 4835001. DOI: 10.3747/co.23.2865. View

Boyd C, Crawford C, Paat C, Price A, Xenakis L, Zhang W . The Impact of Massage Therapy on Function in Pain Populations-A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part II, Cancer Pain Populations. Pain Med. 2016; 17(8):1553-1568. PMC: 4975018. DOI: 10.1093/pm/pnw100. View

Montgomery G, Schnur J, Kravits K . Hypnosis for cancer care: over 200 years young. CA Cancer J Clin. 2012; 63(1):31-44. PMC: 3755455. DOI: 10.3322/caac.21165. View

10.

Anderson K, Cohen M, Mendoza T, Guo H, Harle M, Cleeland C . Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer. 2006; 107(1):207-14. DOI: 10.1002/cncr.21964. View

11.

Bandieri E, Romero M, Ripamonti C, Artioli F, Sichetti D, Fanizza C . Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. J Clin Oncol. 2015; 34(5):436-42. DOI: 10.1200/JCO.2015.61.0733. View

12.

Roditi D, Robinson M . The role of psychological interventions in the management of patients with chronic pain. Psychol Res Behav Manag. 2011; 4:41-9. PMC: 3218789. DOI: 10.2147/PRBM.S15375. View

13.

Humble S, Dalton A, Li L . A systematic review of therapeutic interventions to reduce acute and chronic post-surgical pain after amputation, thoracotomy or mastectomy. Eur J Pain. 2014; 19(4):451-65. PMC: 4405062. DOI: 10.1002/ejp.567. View

14.

Mercadante S, Giarratano A . The long and winding road of non steroidal antinflammatory drugs and paracetamol in cancer pain management: a critical review. Crit Rev Oncol Hematol. 2013; 87(2):140-5. DOI: 10.1016/j.critrevonc.2013.01.001. View

15.

Mantyh P . Bone cancer pain: causes, consequences, and therapeutic opportunities. Pain. 2013; 154 Suppl 1:S54-S62. DOI: 10.1016/j.pain.2013.07.044. View

16.

Cheville A, Basford J . Role of rehabilitation medicine and physical agents in the treatment of cancer-associated pain. J Clin Oncol. 2014; 32(16):1691-702. PMC: 5569680. DOI: 10.1200/JCO.2013.53.6680. View

17.

Wiffen P, Derry S, Naessens K, Bell R . Oral tapentadol for cancer pain. Cochrane Database Syst Rev. 2015; (9):CD011460. PMC: 6483480. DOI: 10.1002/14651858.CD011460.pub2. View

18.

Davies A, Zeppetella G, Andersen S, Damkier A, Vejlgaard T, Nauck F . Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain. 2011; 15(7):756-63. DOI: 10.1016/j.ejpain.2010.12.004. View

19.

Hagen N, Stiles C, Nekolaichuk C, Biondo P, Carlson L, Fisher K . The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a delphi process and patient think-aloud interviews. J Pain Symptom Manage. 2008; 35(2):136-52. DOI: 10.1016/j.jpainsymman.2007.03.016. View

20.

Leppert W . Tramadol as an analgesic for mild to moderate cancer pain. Pharmacol Rep. 2010; 61(6):978-92. DOI: 10.1016/s1734-1140(09)70159-8. View